Cells were treated with TEA684 leading to specific inhibition of ALK phosphorylation (Figure S3) and its downstream targets to determine if the aberrant activation of ALK in the NB cell lines Kelly, SH-EP TET21N and SK-N-SH directly influences chemotherapeutic drugs and their interaction with LCL161 [26]. The gene discussed is ALK; the disease is neuroblastoma.